Intercept Pharmaceuticals to Participate in Cowen’s 43rd Annual Health Care Conference on March 7, 2023
Intercept Pharmaceuticals (Nasdaq: ICPT) announced participation in Cowen’s 43rd Annual Health Care Conference, scheduled for March 7, 2023. CEO Jerry Durso and CFO Andrew Saik will host a fireside chat from 2:10 p.m. to 2:40 p.m. ET. A live audio webcast will be available, alongside an archive for 90 days on the company's investor site. Attendees wishing to meet the management team should contact their representative or reach out to Nareg Sagherian. Intercept focuses on developing therapeutics for progressive non-viral liver diseases such as primary biliary cholangitis and nonalcoholic steatohepatitis.
- None.
- None.
MORRISTOWN, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that Jerry Durso, President and Chief Executive Officer of Intercept, and Andrew Saik, Chief Financial Officer of Intercept, will participate in a fireside chat at Cowen’s 43rd Annual Health Care Conference, taking place in person on Tuesday, March 7, 2023. The Company will also conduct meetings with investors.
Intercept's fireside chat will take place from 2:10 p.m. – 2:40 p.m. ET. A live audio webcast of the event can be found here. The webcast will also be available on the investor page of Intercept’s website as an audio archive for approximately 90 days following the live discussion. Investors attending the conference who wish to meet with the Intercept management team, please reach out to your representative or contact Nareg Sagherian.
About Intercept
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH) and severe alcohol-associated hepatitis (sAH). For more information, please visit www.interceptpharma.com or connect with the Company on Twitter and LinkedIn.
Contact
For more information about Intercept, please contact:
Investor inquiries: investors@interceptpharma.com
Media inquiries: media@interceptpharma.com
FAQ
When is the Cowen’s 43rd Annual Health Care Conference taking place for Intercept Pharmaceuticals?
What time will the fireside chat for Intercept Pharmaceuticals occur at the conference?
Where can I find the live audio webcast of Intercept Pharmaceuticals' fireside chat?
Who will represent Intercept Pharmaceuticals at the Cowen conference?
What diseases does Intercept Pharmaceuticals focus on treating?
